Picture of Verastem logo

VSTM — Verastem News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Brief: Verastem Oncology Provides A Clinical Update For Ramp 203 Trial

Dec 18 (Reuters) - Verastem Inc  VSTM.O :
    * VERASTEM ONCOLOGY PROVIDES A CLINICAL UPDATE FOR RAMP 203
TRIAL
IN ADVANCED KRAS G12C MUTANT NON-SMALL CELL LUNG CANCER
    * NO DOSE-LIMITING TOXICITIES OBSERVED IN TRIPLET
COMBINATION

Source text:  ID:nBw5PpQr9a 
Further company coverage:  VSTM.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Verastem

See all news